Merit Medical Systems, Inc. Stock

$91.12

2.63%

Nasdaq, Jul 07, 10:14 pm CET

ISIN

US5898891040

Symbol

MMSI

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Merit Medical Systems, Inc. Stock price

$91.12

+47.55 109.13% 5Y

Nasdaq, Closing price Mon, Jul 07 2025

-2.46 2.63%

ISIN

US5898891040

Symbol

MMSI

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

$5.5b

Enterprise Value

$5.9b

Net debt

$335.1m

Cash

$395.5m

Shares outstanding

59.1m

Valuation (TTM | estimate)

P/E

47.0 | 27.4

P/S

4.0 | 3.7

EV/Sales

4.2 | 3.9

EV/FCF

32.9

P/B

3.9

Financial Health

Equity Ratio

57.0%

Return on Equity

8.7%

ROCE

7.1%

ROIC

6.4%

Debt/Equity

0.5

Financials (TTM | estimate)

Revenue

$1.4b | $1.5b

EBITDA

$281.1m | $337.5m

EBIT

$160.8m | $270.6m

Net Income

$122.3m | $201.5m

Free Cash Flow

$178.1m

Growth (TTM | estimate)

Revenue

8.2% | 11.7%

EBITDA

22.4% | 21.0%

EBIT

20.5% | -

Net Income

20.0% | 67.4%

Free Cash Flow

36.6%

EPS

$2.0

FCF per Share

$3.0

Short interest

7.8%

Employees

Rev per Employee

$180.0k

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

Get Started for Free Today

Merit Medical Systems, Inc. Stock Analysis

Unlock Scores for Free

??

17 Analysts have issued a Merit Medical Systems, Inc. forecast:

15x Buy

88%

More details on Analyst Estimates Including Price Targets

17 Analysts have issued a Merit Medical Systems, Inc. forecast:

Buy

88%

Hold

12%

Analyst Estimates with Stock Price Targets

Financial data from Merit Medical Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	1,388 1,388	8% 8% 100%
- Direct Costs	725 725	6% 6% 52%
Gross Profit	664 664	11% 11% 48%
- Selling and Administrative Expenses	404 404	7% 7% 29%
- Research and Development Expense	88 88	5% 5% 6%
EBITDA	281 281	22% 22% 20%
- Depreciation and Amortization	120 120	25% 25% 9%
EBIT (Operating Income) EBIT	161 161	21% 21% 12%
Net Profit	122 122	20% 20% 9%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Merit Medical Systems, Inc. Stock News

Neutral

GlobeNewsWire

●

about 5 hours ago

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit's new President and Chief Executi...

Neutral

GlobeNewsWire

●

4 days ago

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wed...

Neutral

Barrons

●

28 days ago

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

Stocks that aren't sensitive to economic ups and downs are a smart way to protect your portfolio.

More Merit Medical Systems, Inc. News

Company Profile

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Head office	United States
CEO	Fred Lampropoulos
Employees	7,400
Founded	1987
Website	www.merit.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now